down arrow

SMS Pharma.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE812G01025
  • NSEID: SMSPHARMA
  • BSEID: 532815
INR
204.10
5.9 (2.98%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 65.74 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Rs cr
Consolidate Quarterly Results
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Jun'23
Net Sales
173.35
196.75
164.45
245.80
161.48
166.64
135.34
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
173.35
196.75
164.45
245.80
161.48
166.64
135.34
Raw Material Cost
118.32
158.77
107.24
97.47
132.48
103.59
91.72
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-32.83
-43.08
-19.28
63.22
-41.22
-5.78
-17.22
Employee Cost
18.64
17.93
16.88
20.12
15.01
14.57
13.55
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
20.75
22.00
18.20
21.86
19.48
18.69
13.38
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
15.26
9.66
7.90
9.51
6.73
7.75
7.73
Total Expenditure (Excl Depreciation)
140.14
165.28
130.94
212.18
132.48
138.82
109.16
Operating Profit (PBDIT) excl Other Income
33.21
31.47
33.51
33.62
29.00
27.82
26.18
Other Income
2.13
1.30
1.37
1.65
1.49
0.81
0.51
Operating Profit (PBDIT)
35.34
32.77
34.88
35.27
30.49
28.63
26.69
Interest
4.20
4.61
4.67
5.61
5.95
5.57
6.32
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
31.14
28.16
30.21
29.66
24.54
23.06
20.37
Depreciation
8.70
8.62
8.38
7.92
8.01
7.90
7.69
Profit Before Tax
22.44
19.54
21.83
21.74
16.53
15.16
12.68
Tax
5.36
5.68
5.46
5.69
4.24
3.11
3.87
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.08
13.86
16.37
16.05
12.29
12.05
8.81
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.08
13.86
16.37
16.05
12.29
12.05
8.81
Share in Profit of Associates
1.16
0.24
0.10
1.23
-0.81
-0.32
0.53
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
18.24
14.10
16.48
17.28
11.48
11.73
9.34
Equity Capital
8.47
8.47
8.47
8.47
8.47
8.47
8.47
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
2.15
1.66
1.95
2.04
1.36
1.38
1.1
Diluted Earnings per share
2.15
1.67
1.95
2.04
1.36
1.39
1.1
Operating Profit Margin (Excl OI)
19.16%
15.99%
20.38%
13.68%
17.96%
16.69%
19.34%
Gross Profit Margin
17.96%
14.31%
18.37%
12.07%
15.2%
13.84%
15.05%
PAT Margin
9.85%
7.04%
9.95%
6.53%
7.61%
7.23%
6.51%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2024 is -11.89% vs 19.64% in Sep 2024

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2024 is 29.36% vs -14.44% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2024 is 5.53% vs -6.09% in Sep 2024

stock-summary

Interest

QoQ Growth in quarter ended Dec 2024 is -8.89% vs -1.28% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024

Compare Quarterly Results Of SMS Pharma. With
Markets Mojo
Figures in Rs cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
173.35
3,230.00
-3,056.65
-94.63%
Other Operating Income
0.00
0.00
0.00
Total Operating income
173.35
3,230.00
-3,056.65
-94.63%
Raw Material Cost
118.32
536.11
-417.79
-77.93%
Purchase of Finished goods
0.00
387.30
-387.30
-100.00%
(Increase) / Decrease In Stocks
-32.83
11.81
-44.64
-377.98%
Employee Cost
18.64
709.71
-691.07
-97.37%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
20.75
0.00
20.75
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
15.26
755.27
-740.01
-97.98%
Total Expenditure (Excl Depreciation)
140.14
2,400.20
-2,260.06
-94.16%
Operating Profit (PBDIT) excl Other Income
33.21
829.80
-796.59
-96.00%
Other Income
2.13
77.32
-75.19
-97.25%
Operating Profit (PBDIT)
35.34
907.12
-871.78
-96.10%
Interest
4.20
220.93
-216.73
-98.10%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
31.14
686.19
-655.05
-95.46%
Depreciation
8.70
192.30
-183.60
-95.48%
Profit Before Tax
22.44
497.33
-474.89
-95.49%
Tax
5.36
112.81
-107.45
-95.25%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
17.08
381.08
-364.00
-95.52%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
17.08
381.08
-364.00
-95.52%
Share in Profit of Associates
1.16
3.44
-2.28
-66.28%
Minority Interest
0.00
4.29
-4.29
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
18.24
380.23
-361.99
-95.20%
Equity Capital
8.47
40.06
-31.59
-78.86%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
2.15
9.49
-7.34
-77.34%
Diluted Earnings per share
2.15
9.44
-7.29
-77.22%
Operating Profit Margin (Excl OI)
19.16%
25.69%
0.00
-6.53%
Gross Profit Margin
17.96%
21.24%
0.00
-3.28%
PAT Margin
9.85%
11.90%
0.00
-2.05%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 173.35 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -11.89% vs 19.64% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 7.35% vs 8.52% in Dec 2023

Quarterly - Consolidate Net Profit
Consolidate Net Profit 18.24 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 29.36% vs -14.44% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 58.89% vs 205.32% in Dec 2023

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 33.21 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 5.53% vs -6.09% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 14.52% vs 56.67% in Dec 2023

Quarterly - Interest
Interest 4.20 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is -8.89% vs -1.28% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -29.41% vs 0.17% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.16%
in Dec 2024

Figures in Rs %
stock-summary

QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023